Literature DB >> 32940725

Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.

Ke Wan1, Yafei Yin2, Zimian Luo3, Jianzhao Cheng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32940725     DOI： 10.1007/s00277-020-04269-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

Review 1.  Anti-erythropoietin antibodies and pure red cell aplasia.

Authors:  Jerome Rossert; Nicole Casadevall; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

2.  The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay.

Authors:  Richard Tacey; Anthony Greway; Janice Smiell; David Power; Arno Kromminga; Mohamed Daha; Nicole Casadevall; Marian Kelley
Journal:  J Immunol Methods       Date:  2003-12       Impact factor: 2.303

3.  Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.

Authors:  David Verhelst; Jérôme Rossert; Nicole Casadevall; Anne Krüger; Kai-Uwe Eckardt; Iain C Macdougall
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

4.  Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

Authors:  Nan Chen; Chuanming Hao; Bi-Cheng Liu; Hongli Lin; Caili Wang; Changying Xing; Xinling Liang; Gengru Jiang; Zhengrong Liu; Xuemei Li; Li Zuo; Laimin Luo; Jianqin Wang; Ming-Hui Zhao; Zhihong Liu; Guang-Yan Cai; Li Hao; Robert Leong; Chunrong Wang; Cameron Liu; Thomas Neff; Lynda Szczech; Kin-Hung P Yu
Journal:  N Engl J Med       Date:  2019-07-24       Impact factor: 91.245

5.  Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

Authors:  Nan Chen; Chuanming Hao; Xiaomei Peng; Hongli Lin; Aiping Yin; Li Hao; Ye Tao; Xinling Liang; Zhengrong Liu; Changying Xing; Jianghua Chen; Laimin Luo; Li Zuo; Yunhua Liao; Bi-Cheng Liu; Robert Leong; Chunrong Wang; Cameron Liu; Thomas Neff; Lynda Szczech; Kin-Hung P Yu
Journal:  N Engl J Med       Date:  2019-07-24       Impact factor: 91.245
  5 in total
  1 in total

1.  Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone.

Authors:  Nozomi Okahashi; Masayuki Kubo; Ei Hoshino; Masahito Uchihara; Itsuto Amano; Haruyuki Tanaka
Journal:  Intern Med       Date:  2021-12-28       Impact factor: 1.282
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.